“This market-first simulation keeps Immersion at the forefront of innovation in highly sophisticated medical training that helps improve the quality of healthcare all over the world,” said Daniel Chavez, senior vice president and general manager of Immersion’s Medical line of business. “By combining realistic touch feedback with our virtual reality environments that provide true-to-life simulation, Immersion is helping more and more doctors become skilled at critical new techniques that can save lives every day.”
“Endobronchial ultrasound has been shown to be effective in significantly increasing the yield of sampling enlarged thoracic lymph nodes and facilitating the staging of lung cancer in a minimally-invasive fashion. Unfortunately, the learning curve for EBUS is fairly steep,” said Dr. Momen Wahidi, MD, MBA, and Director of Interventional Pulmonology at Duke University Medical Center, Durham, NC. “The EBUS-TBNA simulation model created by Immersion should greatly enhance the learning of the large number of pulmonologists and thoracic surgeons who are eager to learn EBUS-TBNA and introduce it to their practice.”
EBUS has been shown to be an effective tool for imaging and sampling mediastinal nodes. However, due to several factors such as an angled camera view and difficult to interpret ultrasound images, it requires intense training and can take over 50 procedures to learn. By using advanced virtual reality simulation to train, medical schools and institutions can provide a risk-free, cost-saving, and highly effective way for medical students, residents, and practicing physicians to master the EBUS procedure.
Immersion provides the most cutting-edge methods of training for challenging procedures that help ensure better healthcare outcomes for a population that faces staggering mortality rates. Lung cancer has an extremely high mortality rate of 94% in the U.S., with approximately 160,000 deaths occurring from 170,000 cases diagnosed each year. According to the World Health Organization, lung cancer causes more deaths worldwide than any other cancer. It accounts for about 1.4 million deaths each year, or 17.7 percent of all cancer deaths.
EBUS-TBNA provides a minimally invasive alternative to mediastinoscopy, the traditional method of staging lung cancer. Additionally, the image guided component increases yields versus traditional “blind” TBNA techniques. EBUS-TBNA can offer ongoing cost savings by avoiding the need for mediastinoscopy and other more expensive procedures for some patients.
Endoscopic and bronchoscopic procedures are commonly practiced medical procedures today. However, the motor skills necessary to perform these are difficult to train and assess. Immersion’s EBUS-TBNA module for its EndoscopyVR System provides several key benefits, including:
About Immersion’s Medical Line of Business
Immersion designs, manufactures, and markets computer-based surgical
simulation training systems worldwide. The medical and surgical
simulators integrate proprietary computer software and tactile feedback
robotics to create highly realistic medical simulations that help train
clinicians. The company's key product lines are the LaparoscopyVR
surgical simulation system, Endoscopy AccuTouch(R) simulator, CathLabVR
surgical simulator, and the Virtual IV system.